Sustained emotional state lasting hours to days that colors perception, motivation, and behavior. Unlike emotions (brief, stimulus-triggered, discrete), mood is diffuse, pervasive, and operates as a neurometabolic background signal that integrates inflammatory tone, neurotransmitter balance, circadian phase, and metabolic state. Mood functions as an interoceptive readout of the body's resource availability and immune-metabolic stability, signaling the organism's readiness to engage with environmental challenges.
Mood is like the ambient lighting in a theater that changes how every scene appears. The same stage set (your environment) looks inviting under warm yellow lights, threatening under harsh blue-white fluorescents, or flat and colorless under dim grey bulbs. The lighting doesn't change the objects on stage, but it changes your entire perception of them β your willingness to approach, your sense of safety, your energy to engage.
The lighting control board is managed by multiple technicians who don't always coordinate: the monoamine crew (serotonin, dopamine, norepinephrine) adjusts color temperature; the inflammatory crew (cytokines, microglia) dims the lights when the "building" needs maintenance; the metabolic crew (glucose, ketones, lactate) controls brightness based on available power; and the circadian crew gradually shifts hues throughout the 24-hour cycle. When these crews communicate well, the lighting feels natural and responsive. When they miscommunicate β when inflammation cranks the lights into harsh interrogation mode while circadian rhythms are trying to dim for evening, or when metabolic brownouts cause flickering β the entire theater experience becomes distorted, even if the script and actors haven't changed.
Critically, the audience (you) can't directly see the control board. You only experience the lighting, and you interpret it as something about the stage itself β "this situation is hopeless" rather than "my inflammatory system is running a maintenance protocol that's affecting my perception."
Mood emerges from convergent signaling across multiple neuroendocrine-immune axes, integrated primarily in limbic-prefrontal circuits:
Monoamine Foundation:
Inflammatory Modulation:
Metabolic Inputs:
Circadian Integration:
- Circadian rhythm genes (Clock, Bmal1, Per, Cry) regulate transcription of monoamine synthetic enzymes and receptors
- Melatonin from pineal gland coordinates nocturnal mood shift toward lower arousal
- Cortisol peak at awakening (06:00-08:00) should enhance arousal and positive anticipation; flattened or delayed cortisol curves predict negative morning mood
- Sleep deprivation acutely disrupts prefrontal control, enhancing amygdala reactivity and inflammatory tone
Gut-Brain Signaling:
graph TD
A[Peripheral Inflammation] -->|"IL-6, TNF-Ξ±, IL-1Ξ²"| B[Brain Entry]
B --> C[Microglial Activation]
C --> D[IDO Activation]
D --> E["Tryptophan β Kynurenine"]
E --> F["β Serotonin Synthesis"]
E --> G["β Quinolinic Acid"]
C --> H["β BDNF"]
H --> I[Impaired Neuroplasticity]
A --> J[HPA Axis Activation]
J --> K[Cortisol Release]
K --> L[GR Desensitization]
L --> M[Loss of Negative Feedback]
M --> A
F --> N[Negative Mood]
G --> N
I --> N
O[Metabolic Dysfunction] --> P[Insulin Resistance]
P --> Q[Brain Glucose Hypometabolism]
Q --> N
R[Circadian Disruption] --> S[Dysregulated Cortisol]
S --> N
T[Gut Dysbiosis] --> U["β SCFA, β LPS"]
U --> A
Mood disturbances are cardinal features across psychiatric diagnoses (Depression, Anxiety, bipolar disorder) but represent the final common pathway of neuroimmunometabolic dysregulation visible in chronic inflammatory conditions, autoimmune diseases, metabolic syndrome, chronic pain, chronic fatigue syndrome, and cancer.
cPNI Assessment Framework:
In clinical practice, mood serves as a real-time biomarker of inflammatory burden, metabolic flexibility, and circadian alignment. Persistent negative mood despite adequate sleep and nutrition suggests chronic inflammatory activation. Morning mood particularly reflects cortisol awakening response and overnight inflammatory resolution β inability to "reset" mood overnight indicates failed resolution processes.
Evolutionary Context:
Low mood functionally represents sickness behaviour β the evolved behavioral suite (social withdrawal, anhedonia, psychomotor slowing, anorexia) that conserves energy during infection and prevents pathogen transmission. In modern environments, chronic low-grade inflammation from sedentarism, processed foods, circadian disruption, and psychosocial stress inappropriately triggers this ancient program without actual infection, producing the clinical picture of "depression" as mismatch disease.
Intervention Implications:
Clinical Thresholds:
- IL-6 >5 pg/mL correlates with depressive symptoms in healthy populations; >10 pg/mL predicts poor antidepressant response
- CRP >3 mg/L associated with increased depression risk and treatment resistance
- Cortisol awakening response <2.5 nmol/L increase or delayed peak predicts negative morning mood
- Omega-3 index <4% associated with depression risk; >8% protective
- HbA1c >5.7% associated with mood instability independent of diabetes diagnosis
Metamodel Integration:
- Selfish Systems: Low mood represents the selfish immune system prioritizing pathogen defense over reproduction, social engagement, and exploration
- 5+2 Metamodel: Mood integrates signals from all systems β inflammation (immune), neurotransmitter balance (neuro), cortisol/insulin (endocrine), SCFA/dysbiosis (gut), glucose metabolism (metabolic)
- Intermittent Living: Mood benefits from oscillation β brief stress/challenge followed by recovery enhances resilience; chronic unremitting stress depletes it
- 30-40% of patients with chronic inflammatory diseases (RA, IBD, MS) meet criteria for major depression independent of disability burden
- IL-6 levels >5 pg/mL correlate with depressive symptoms in otherwise healthy populations; levels >10 pg/mL predict non-response to SSRIs
- Single 30-minute bout of aerobic Exercise produces measurable mood improvement within 10-30 minutes via Endorphin, anandamide, and lactate signaling
- Sleep deprivation for 24 hours acutely improves mood in 40-60% of depressed patients by temporarily resetting inflammatory and monoamine systems (non-sustainable intervention)
- Omega-3 fatty acids supplementation (1-2g EPA daily) demonstrates antidepressant effects equivalent to SSRIs in meta-analyses, particularly in patients with elevated inflammatory markers
- Gut microbiome diversity inversely correlates with depression severity; dysbiosis predicts treatment-resistant depression
- BDNF Val66Met polymorphism carriers show reduced activity-dependent BDNF release and increased depression risk
- Morning Cortisol peak (06:00-08:00) should be 50-100% above baseline; flattened curve predicts negative mood throughout day
- Kynurenine pathway activity (kynurenine/tryptophan ratio) elevated in depression, directly reducing Serotonin availability
- Anti-inflammatory interventions (EPA, curcumin, exercise) show largest mood effects in patients with CRP >3 mg/L, minimal effect with CRP <1 mg/L
- Insulin resistance in brain (measured by FDG-PET) predicts cognitive slowing and negative mood independent of peripheral insulin sensitivity
- Circadian disruption from shift work increases depression risk 1.5-2x; restoring regular sleep-wake cycles improves mood within 2-4 weeks
- Depression β persistently low mood is the defining feature; in cPNI understood as neuroimmunometabolic syndrome rather than pure psychiatric disorder
- dopamine β mesolimbic and mesocortical dopamine signaling underlies motivational ("wanting") and hedonic ("liking") components of positive mood
- serotonin β serotonergic tone from raphe nuclei stabilizes mood and gates emotional reactivity; low 5-HT associated with impulsivity and negative rumination
- inflammation β peripheral and central inflammatory signaling is primary mechanism linking medical illness to mood disturbance
- IL-6 β elevated interleukin-6 directly predicts depression severity and treatment resistance via IDO activation
- TNF-Ξ± β tumor necrosis factor alpha reduces BDNF expression and disrupts synaptic plasticity underlying mood regulation
- neuroinflammation β microglial activation in limbic circuits impairs reward processing and threat discrimination
- BDNF β brain-derived neurotrophic factor supports hippocampal neurogenesis and prefrontal plasticity required for mood resilience
- HPA axis β chronic HPA activation with cortisol resistance contributes to mood dysregulation through inflammatory amplification
- gut microbiome β dysbiosis predicts depression through reduced SCFA production, increased LPS translocation, and vagal signaling alterations
- SCFA β short-chain fatty acids, especially butyrate, enhance BDNF expression and reduce neuroinflammation supporting positive mood
- Insulin resistance β brain insulin resistance impairs glucose metabolism in prefrontal and limbic regions, disrupting mood circuits
- circadian rhythm β disrupted circadian biology flattens cortisol curve and desynchronizes neurotransmitter cycling, causing mood instability
- sleep β sleep quality is bidirectionally linked to mood; poor sleep amplifies inflammatory tone and impairs prefrontal regulation
- Exercise β physical activity rapidly enhances mood through multiple pathways: endorphins, endocannabinoids, lactate, BDNF, anti-inflammatory shift
- omega-3 fatty acids β EPA/DHA supplementation shows antidepressant effects by reducing inflammatory signaling and enhancing membrane fluidity
- kynurenine pathway β inflammatory activation shunts tryptophan away from serotonin synthesis toward neurotoxic quinolinic acid
- Prefrontal cortex β dorsolateral and ventromedial PFC provide top-down regulation of limbic emotional responses; hypometabolism predicts negative mood
- Amygdala β amygdala hyperreactivity to negative stimuli with reduced prefrontal inhibition characterizes depression and anxiety
- chronic pain β shares neuroinflammatory mechanisms with depression; anti-inflammatory interventions improve both simultaneously
- cytokines β pro-inflammatory cytokines induce sickness behavior constellation including negative mood as evolved response to infection
- blood-brain barrier β BBB disruption in depression allows increased peripheral inflammatory signal entry
- Vagus nerve β vagal afferents transmit peripheral cytokine signals to brainstem, initiating mood changes before conscious awareness
- Tryptophan β essential amino acid precursor for serotonin; inflammation diverts it to kynurenine pathway reducing mood-stabilizing serotonin
- IDO β indoleamine 2,3-dioxygenase is rate-limiting enzyme activated by inflammation that depletes tryptophan for serotonin synthesis
- microbiome β specific bacterial strains modulate mood through SCFA production, neurotransmitter precursors, and immune training
- Cortisol β cortisol awakening response and diurnal curve shape predict mood throughout day; dysregulated cortisol contributes to mood disorders
- chronic fatigue β fatigue and low mood are often comorbid, sharing inflammatory and metabolic dysfunction mechanisms
- autoimmune conditions β autoimmune diseases show 2-3x higher depression rates due to chronic inflammatory signaling to brain